EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Low Alkaline Phosphatase Levels in Clinical Practice: Implications for Diagnosing Hypophosphatasia

Gonul Buyukyilmaz iD, Serkan Bilge Koca iD, Refika Gören iD, Andac Uzdogan iD, Keziban Toksoy Adıguzel iD, Aylin Kılınç Uğurlu iD, Gonul Yardimci iD, Pınar Kocaay iD, Derya Tepe iD, Mehmet Boyraz iD, Esra Kilic iD, Fatih Gürbüz iD

Calcified Tissue International · 19.08.2025 · 116 (1)

DOI: 10.1007/s00223-025-01424-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Calcified Tissue International, online erschienen am 19.08.2025. Verfasst von Gonul Buyukyilmaz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, Ankara Bilkent City Hospital, Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Türkiye. gonulgu…. Hauptthemen laut MEDLINE: Hypophosphatasia, Alkaline Phosphatase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Persistent low serum alkaline phosphatase (ALP) levels are crucial in identifying genetic disorders such as hypophosphatasia (HPP). This study investigates the causes of low ALP levels in children, aiming to evaluate the demographic and clinical characteristics of those diagnosed with HPP.We evaluated 2243 children and adolescents, ranging from 0 to 19 years old between September 2019 and July 2024, who exhibited at least two ALP levels below the age- and gender-specific lower limit.In the patient group, 95.4% (2140 patients) exhibited transient low ALP levels, while 4.6% (103 patients) showed persistently low levels. In the persistent group, eleven additional medical conditions were identified, excluding HPP, with calorie depletion (anorexia, malnutrition) being the most common cause. The study identified 16 HPP patients (10 females, 6 males) with high phenotypic variability even within the same variants, comprising 0.71% of the whole group. Genetic testing identified 13 pathogenic/likely pathogenic ALPL gene variants (10 heterozygous, 3 homozygous), two of which were novel. Among HPP patients, 56.2% presented with HPP-related symptoms, most commonly short stature. We found a significant negative correlation between total ALP and serum pyridoxal phosphate (PLP) levels (Rho = - 0.55, p = 0.039), but no correlation with urine phosphoethanolamine.Persistently low ALP levels are a vital clinical indicator for a wide range of disorders, especially HPP. This study expands the phenotypic and genotypic profiles of HPP while improving our understanding of the disease in children. Increasing disease awareness, particularly for milder forms, is essential to avoid delayed diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypophosphatasiaAlkaline PhosphataseHumansFemaleMaleChildAdolescentChild, PreschoolInfantYoung AdultInfant, Newborn

Stichwörter der Autor:innen

ALPLAlkaline phosphataseHypophosphatasiaPhenotypic variabilityPyridoxal-5-phosphate

Substanzen

Alkaline PhosphataseALPL protein, human

Autor:innen und Institutionen

  • Department of Pediatric Endocrinology, Ankara Bilkent City Hospital, Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Türkiye. gonulgulal@hotmail.com.
  • Department of Pediatric Endocrinology, Kayseri City Education and Research Hospital, Kayseri, Türkiye.
  • Department of Pediatric Endocrinology, Ankara Bilkent City Hospital, Ankara, Türkiye.
  • Department of Medical Biochemistry, Ankara Bilkent City Hospital, Ankara, Türkiye.
  • Department of Pediatric Endocrinology,, Dr. Burhan Nalbantoğlu State Hospital, Nicosia, Northern Cyprus.
  • Department of Pediatric Endocrinology, Gazi University Faculty of Medicine Hospital, Ankara, Türkiye.

ORCID-Profile: Gonul Buyukyilmaz, Serkan Bilge Koca, Refika Gören, Andac Uzdogan, Keziban Toksoy Adıguzel, Aylin Kılınç Uğurlu, Gonul Yardimci, Pınar Kocaay, Derya Tepe, Mehmet Boyraz, Esra Kilic, Fatih Gürbüz

Zitieren

APA

Buyukyilmaz, G., Koca, S. B., Gören, R., Uzdogan, A., Adıguzel, K. T., Uğurlu, A. K., Yardimci, G., Kocaay, P., Tepe, D., Boyraz, M., Kilic, E., & Gürbüz, F. (2025). Evaluation of Low Alkaline Phosphatase Levels in Clinical Practice: Implications for Diagnosing Hypophosphatasia. Calcified Tissue International, 116(1). https://doi.org/10.1007/s00223-025-01424-3

Vancouver

Buyukyilmaz G, Koca SB, Gören R, Uzdogan A, Adıguzel KT, Uğurlu AK, et al. Evaluation of Low Alkaline Phosphatase Levels in Clinical Practice: Implications for Diagnosing Hypophosphatasia. Calcified Tissue International. 2025;116(1). doi:10.1007/s00223-025-01424-3

BibTeX
@article{Buyukyilmaz2025,
  author = {Buyukyilmaz, Gonul and Koca, Serkan Bilge and Gören, Refika and Uzdogan, Andac and Adıguzel, Keziban Toksoy and Uğurlu, Aylin Kılınç and Yardimci, Gonul and Kocaay, Pınar and Tepe, Derya and Boyraz, Mehmet and Kilic, Esra and Gürbüz, Fatih},
  title = {Evaluation of Low Alkaline Phosphatase Levels in Clinical Practice: Implications for Diagnosing Hypophosphatasia},
  journal = {Calcified Tissue International},
  year = {2025},
  volume = {116},
  number = {1},
  doi = {10.1007/s00223-025-01424-3}
}
Kostenlos starten →